Scleral buckling or PPV can treat rhegmatogenous RD in BD

Article

Scleral buckling or pars plana vitrectomy (PPV) can be used to treat rhegmatogenous retinal detachment (RD) associated with Beh?et's disease (BD), according to researchers in the Department of Ophthalmology, Zagazig University, Egypt.

Scleral buckling or pars plana vitrectomy (PPV) can be used to treat rhegmatogenous retinal detachment (RD) associated with Behçet's disease (BD), according to researchers in the Department of Ophthalmology, Zagazig University, Egypt.

The researchers retrospectively reviewed the medical records of all patients at their institution who had undergone surgical intervention for rhegmatogenous RD associated with BD between June 2007 and June 2012. They reported their results in BMC Ophthalmology.

The study included 7 eyes of 7 patients. Five eyes were treated with scleral buckling (4 segmental buckle and 1 encircling buckle); 2 eyes were treated with PPV. One eye initially treated by scleral buckling showed recurrence of RD and was subsequently treated with PPV. All 7 retinas were successfully reattached at the end of a follow-up period of 22.0 (± 6.7) months.

"Rhegmatogenous RD is a rare posterior segment complication of BD but it should be kept in mind, especially if the patient presented with marked diminution of vision on top of the chronic course of the disease, and careful examination should be considered especially in cases with media opacity," the researchers wrote. "Segmental scleral buckle or PPV are effective and safe in management of this complication in BD patients with no unusual complications."

The researchers added that 3 of the patients had a history of receiving an intravitreal injection of triamcinolone acetonide to treat attacks of panuveitis or resistant cystoid macular oedema, and in all cases their RD occurred within 8 weeks of the injection. This led them to speculate that intravitreal injection of triamcinolone acetonide may be a precipitating factor for the development of rhegmatogenous RD, and they urged close observation of such patients after injection.

To read the entire article, go to the journal's website.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Related Content
© 2025 MJH Life Sciences

All rights reserved.